CD123 - Overview: CD123 Immunostain, Technical Component Only
Marker of plasmacytoid monocytes, mast cells, and megakaryocytes
CMET - Overview: cMET Immunostain, Technical Component Only
Identification of normal and neoplastic c-Met expressing cells
PDSUX - Overview: Drug Screen, Prescription/Over the Counter, Chain of Custody, Random, Urine
Qualitative detection and identification of prescription or over-the-counter drugs frequently found in drug overdose or used with a suicidal intent Providing, when possible, the identification of all drugs in the specimen This test is...
CERS - Overview: Ceruloplasmin, Serum
Investigation of patients with possible Wilson disease
MCEA - Overview: Carcinoembryonic Antigen, Monoclonal Immunostain, Technical Component Only
Marker of epithelial cells
CD99 - Overview: CD99 (MIC-2) Immunostain, Technical Component Only
Identification of Ewing sarcoma and primitive neuroectodermal tumors
CRPCR - Overview: Carbapenem Resistance Genes, Molecular Detection, PCR, Rectal Swab
Detecting and differentiating the blaKPC, blaNDM, blaVIM, blaOXA-48, and blaIMP gene sequences associated with carbapenem intermediate or resistant results Aiding in infection control in the detection of gastrointestinal colonization of...
CALD - Overview: Caldesmon Immunostain, Technical Component Only
As a marker of smooth muscle differentiation
CD10 - Overview: CD10 Immunostain, Technical Component Only
Phenotyping leukemias and lymphomas
HSCRP - Overview: C-Reactive Protein, High Sensitivity, Serum
Assessment of risk of developing myocardial infarction in patients presenting with acute coronary syndromes Assessment of risk of developing cardiovascular disease or ischemic events in individuals who do not manifest disease at present
Mayo Clinic Ranked No. 1 Hospital Nationwide by U.S. News & World Report - Insights
Report’s 29th annual "Best Hospitals Honor Roll" published online on August 14. Mayo Clinic also ranked No. 1 in more specialties than any other hospital in the country....
NELL-1 [Test in Focus] - Insights
D., discusses how Mayo Clinic Laboratories’ new immunohistochemistry test for the detection of NELL-1 antigen, a biomarker for membranous nephropathy found in 10% to 15% of patients, provides diagnostic...
Looking Back on Clinical Chemistry 1 - Insights
in the Mayo Clinic Medical Laboratory Science program, takes a look back on her Clinical Chemistry 1 course....
Orexin-A/Hypocretin-1 for the Diagnosis of Type 1 Narcolepsy [Test in Focus] - Insights
test to perform as well as to interpret. The orexin-A/hypocretin-1 test is a sensitive and specific alternative to the MSLT to diagnose type 1 narcolepsy....
Week in Review: November 1 - Insights
Top highlights include: Facebook launches into the digital space of healthcare, medical breakthrough for Ebola, and how the brain makes memories.